1
ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:February 24, 2023Recruiting
Metastatic Solid Tumors: 4968 Clinical Trials, Page 1 of 497
Hide Studies Not Open or Pending
2
A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours
Condition(s):Cancer: Recurrent and/or Metastatic Solid TumoursLast Updated:July 14, 2022Recruiting
3
Treatment of Advanced and Metastatic Solid Tumors With MIL97
Condition(s):Advanced or Metastatic Solid TumorLast Updated:January 19, 2023Recruiting
4
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Condition(s):Advanced or Metastatic Solid Tumor MalignanciesLast Updated:January 9, 2023Recruiting
5
A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours
Condition(s):Advanced or Metastatic Solid TumoursLast Updated:February 25, 2014Completed
6
Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.
Condition(s):Locally Advanced Solid Tumours; Metastatic Solid Tumours; Ovarian CancerLast Updated:December 12, 2018Completed
7
A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors
Condition(s):Advanced Solid Tumor; Metastatic Solid TumorLast Updated:February 9, 2023Recruiting
8
ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:April 4, 2022Recruiting
9
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:February 10, 2023Recruiting
10
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:February 21, 2023Recruiting